Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 134 results for "sun pharma advanced research"

Sun Pharma arm suffers US jolt
Calcutta Telegraph

Sun Pharma arm suffers US jolt

Mumbai, Sept. 26: In a setback to Sun Pharma Advanced Research Company (SPARC), the US Food and Drug Administration (USFDA) has revoked an approval for its anti-epileptic drug because of manufacturing quality concerns at the Halol plant of Sun ... Calcutta Telegraph, 1 week ago
IPM clocks Rs 8281 crores in Aug 2015 Financial Express, 3 days ago
Pharmaceutical Manufacturing Magazine

FDA Revokes Approval for Sun Pharma Drug Over GMP Issues

The U.S. FDA has revoked an approval granted in March to India's Sun Pharma Advanced Research Company (SPARC) to launch a drug for seizures, citing manufacturing quality issues. Elepsia XR was the first FDA-approved drug for SPARC, the research ...
 Pharmaceutical Manufacturing Magazine1 week ago FDA revokes Sun Pharma's approval for epilepsy drug after compliance concerns  BioPharma Dive1 week ago Sun Pharma's scrip down 3.42 pc on US FDA's quality concerns  SME Times1 week ago FDA denies approval for Sun Pharma's drug  Reuters India1 week ago
Financial Express

SPARC, Sun Pharma shares fall as USFDA revokes approval for epilepsy drug

Shares of Sun pharma and its research arm SPARC fell in the morning trade on Monday after the USFDA revoked an approval issued in March to SPARC for an epilepsy drug. (Reuters) Shares of Sun pharma and its research arm Sun Pharma Advanced ...
 Financial Express1 week ago Sun Pharma, SPARC Fall As US Revokes Nod for Epilepsy Drug  NDTV Profit1 week ago Sun Pharma and Sparc: Fall in shares justified?  Livemint.com1 week ago Sun Pharma, SPARC shares fall after US FDA revokes approval for drug  Livemint.com1 week ago

SPARC files draft paper with Sebi for Rs 250cr rights issue

D SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007. Ernst & Young Merchant Banking Services Private Limited, Inga Capital Private Limited are the lead managers to the issue. Earlier in May, the company's ...
 Moneycontrol.com2 weeks ago SPARC files draft papers with Sebi for Rs250 crore rights issue  Livemint.com2 weeks ago
Business Standard India

Sun Pharma's anaemic product pipeline likely to hurt FY16 sales

Sun Pharmaceutical's medium-term outlook continues to be cloudy as far as its Halol facility is concerned. Last week, the US Food and Drug Administration (FDA) revoked the approval issued in March to group company Sun Pharma Advanced Research ...
 Business Standard India1 week ago

Sensex ends 100 pts up; Pharma stocks rally

Metal and realty stocks closed weak. Bank stocks too displayed some weakness, while FMCG, oil and power stocks closed on a mixed note. The BSE benchmark Sensex ended up 100.10 points or 0.36% at 27,931.64, after scaling a low of 27,721.25 and a ...
 Sify1 month ago Sensex up over 158 pts; Pharma, IT stocks trade firm  Sify1 month ago Stocks in news: SPARC, Gammon India and more  Business Today India1 week ago
Business Today India

Indian pharma on road to new drug discovery

It is turning out to be a serious health scare. With bacteria fast developing resistance to existing antibiotics, we may soon reach a stage where a simple bruise may prove fatal. What is making things worse is that no new antibiotic has been ...
 Business Today India1 month ago

Attorney demolishes Pro-Vaccine talking points: Suggests suing U.S. Federal Government & Big Pharma

Finally! it's happened. An attorney feels that the U.S. federal government and Big Pharma must be sued and taken to task legally for their liability in causing false and inaccurate information about vaccines to be disseminated upon which FORCED ...
 Sott.net1 week ago The Vaccine Conspiracy: U.S. Government Colludes With Big Pharma to Poison the American People  Before It's News1 week ago
Sys-Con Media

Cancer Pipeline (Bladder, Nasopharyngeal, Metastatic Prostate Cancer) H2 2015 Review Research Reports on Therapeutic Development

_ adds H2 2015 cancer pipeline review research reports for bladder, nasopharyngeal cancer and metastatic prostate cancer with a focus on their products and therapeutic development. Complete report on Bladder Cancer - Pipeline ...
 Sys-Con Media4 weeks ago

Research Analysts Upgrades for August, 14th (SQI, SREV, STL, STMP, SUNS, SWRAY, TFM, TWOU, TYPE, VIPS)

Research Analysts upgrades for Friday, August 14th: SciQuest (NYSE:SQI) was upgraded by analysts at Zacks from a sell rating to a hold rating. According to Zacks, SciQuest Inc. is a provider of on-demand strategic procurement and supplier ...
 SleekMoney1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
Get updated on latest news & your favorite topics right in your inbox!
More     Less